Search research articles
Contact Us
Filters
Showing results (71-80 of 117) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2011
Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation
Alois Gratwohl, Ronald Brand, Dietger Niederwieser, et al.
Blood
|
May 20, 2006
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani, Giuseppe Saglio, John Goldman, et al.
American Journal of Hematology
|
March 26, 2018
Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation
Anna Czyz, Myriam Labopin, Sebastian Giebel, et al.
Ebiomedicine
|
February 5, 2016
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
Alois Gratwohl, Anna Sureda, Helen Baldomero, et al.
JACC. Cardiooncology
|
October 31, 2024
Cardiovascular Considerations Before Cancer Therapy: Gaps in Evidence and <i>JACC: CardioOncology</i> Expert Panel Recommendations
Zahra Raisi-Estabragh, Alexandra C Murphy, Sivatharshini Ramalingam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2009
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet
Michele Baccarani, Jorge Cortes, Fabrizio Pane, et al.
Blood
|
February 1, 2007
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase
Francois Guilhot, Jane Apperley, Dong-Wook Kim, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 13, 2025
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study
Alexander M K Rothman, Sofia Villar, Jennifer Middleton, et al.
Leukemia
|
January 29, 2024
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials
Elias Jabbour, Jane Apperley, Jorge Cortes, et al.
Haematologica
|
March 23, 2010
Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia
Anne M Dickinson, Kim F Pearce, Jean Norden, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 117) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2011
Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation
Alois Gratwohl, Ronald Brand, Dietger Niederwieser, et al.
Blood
|
May 20, 2006
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani, Giuseppe Saglio, John Goldman, et al.
American Journal of Hematology
|
March 26, 2018
Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation
Anna Czyz, Myriam Labopin, Sebastian Giebel, et al.
Ebiomedicine
|
February 5, 2016
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
Alois Gratwohl, Anna Sureda, Helen Baldomero, et al.
JACC. Cardiooncology
|
October 31, 2024
Cardiovascular Considerations Before Cancer Therapy: Gaps in Evidence and <i>JACC: CardioOncology</i> Expert Panel Recommendations
Zahra Raisi-Estabragh, Alexandra C Murphy, Sivatharshini Ramalingam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2009
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet
Michele Baccarani, Jorge Cortes, Fabrizio Pane, et al.
Blood
|
February 1, 2007
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase
Francois Guilhot, Jane Apperley, Dong-Wook Kim, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 13, 2025
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study
Alexander M K Rothman, Sofia Villar, Jennifer Middleton, et al.
Leukemia
|
January 29, 2024
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials
Elias Jabbour, Jane Apperley, Jorge Cortes, et al.
Haematologica
|
March 23, 2010
Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia
Anne M Dickinson, Kim F Pearce, Jean Norden, et al.
Page
of 12